The dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic
Journal of Cellular and Molecular Immunology · 14.02.2026 · 5 (1) · 5
DOI: 10.46439/immunol.5.041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Immunology, online erschienen am 14.02.2026. Verfasst von Diana Diba Ara und 2 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
We recently engaged with the systematic review by Soheilipour et al.[1], concludes that Akkermansia muciniphila primarily acts as a pathobiont in colorectal cancer (CRC) by exacerbating tumor progression. While the authors provide a comprehensive analysis of the bacterium's pathobiont potential
Zitieren
APA
Ara, D. D., Noursina, A., & Abbasi, F. (2026). The dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic. Journal of Cellular and Molecular Immunology, 5(1), 5. https://doi.org/10.46439/immunol.5.041
Vancouver
Ara DD, Noursina A, Abbasi F. The dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic. Journal of Cellular and Molecular Immunology. 2026;5(1):5. doi:10.46439/immunol.5.041
BibTeX
@article{Ara2026,
author = {Ara, Diana Diba and Noursina, Adel and Abbasi, Fatemeh},
title = {The dichotomous role of A. muciniphila in CRC: from probiotic to postbiotic},
journal = {Journal of Cellular and Molecular Immunology},
year = {2026},
volume = {5},
number = {1},
pages = {5},
doi = {10.46439/immunol.5.041}
}
EUVIMED